-
The therapeutic response to indomethacin is the most reliable differential diagnostic criterion for PH vs CH.
-
In 15%, and without correlation to maternal disease severity or antibody level, neonatal MG due to the transplacental transfer of maternal antibodies results in transient weakness of the newborn that resolves within 12 weeks.
-
-
The FDA has asked Pfizer to withdraw valdecoxib (Bextra) from the market due to safety concerns.
-
The FDA has asked Pfizer to withdraw valdecoxib (Bextra) from the market due to safety concerns.
-
-
In this paper, health effects of secondhand smoke exposure are examined in both children and adults. A brief overview of methods used to screen for secondhand smoke exposure is given. Among the complications discussed are those of cardiovascular, pulmonary, and neurological systems.
-
Although we have recently enjoyed the FDA approval of two agents for treatment of diabetic peripheral neuropathic pain (duloxetine [Cymbalta], pregabalin [Lyrica]), as yet we have no treatment for diabetic peripheral neuropathy (DPN) itself.
-
In 1985 5.6% of pregnant patients were 35 years of age or older, and in 2002 that figure rose to 12.5%. It is estimated that last year 20% of the pregnant population was older than 34 years of age.
-
Is Holding NSAIDs Prior to Surgery Rational?; Low-Dose Aspirin: Men vs Women; FDA Actions
